Phase Ii trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors
Gold, E.J.; Bosl, G.J.; Itri, L.M.
Cancer Treatment Reports 68(10): 1287-1288
1984
ISSN/ISBN: 0361-5960 PMID: 6098365 Document Number: 231372
Document emailed within 1 workday
Related Documents
Reynolds, T.F.; Vugrin, D.; Cvitkovic, E.; Gralla, R.J.; Young, C.W.; Golbey, R.B. 1979: Phase Ii trial of vindesine in patients with germ-cell tumors Cancer Treatment Reports 63(8): 1399-1401Vugrin, D.; Cvitkovic, E.; Whitmore, W.F.; Golbey, R.B. 1979: Adjuvant chemotherapy in resected nonseminomatous germ cell tumors of testis: stages i and Ii Seminars in Oncology 6(1): 94-98
Gerl, A.; Lamerz, R.; Mann, K.; Clemm, C.; Wilmanns, W. 1997: Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors? Anticancer Research 17(4b): 3047-3049
Peckham, M.J. 1979: An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy Cancer Treatment Reports 63(9-10): 1653-1658
Toner, G.C.; Geller, N.L.; Tan, C.; Nisselbaum, J.; Bosl, G.J. 1990: Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors Cancer Research 50(18): 5904-5910
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Rothman, J.; Greenberg, R.E.; Jaffe, W.I. 2008: Nonseminomatous germ cell tumor of the testis 9 years after a germ cell tumor of the pineal gland: case report and review of the literature Canadian Journal of Urology 15(3): 4122-4124
Bosl, G.J.; Geller, N.L.; Chan, E.Y. 1988: Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors Cancer Research 48(12): 3524-3527
Matsukado, Y.; Abe, H.; Tanaka, R.; Kobayashi, T.; Yamashita, J.; Nishimoto, A.; Ushio, Y.; Sato, K.; Matsutani, M.; Takakura, K. 1986: Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group Gan No Rinsho. Japan Journal of Cancer Clinics 32(11): 1387-1393
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Schmoll, H.J.; Bokemeyer, C.; Harstrick, A.; Illiger, H.J.; Metzner, B.; Ruther, U.; Osternamm, A.; Preiss, J.; Wilke, H.; Hohnloser, J. 1992: Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors Pathologie-Biologie 39(9): 961
Motzer, R.J.; Nanus, D.M.; O'Moore, P.; Scher, H.I.; Bajorin, D.F.; Reuter, V.; Tong, W.P.; Iversen, J.; Louison, C.; Albino, A.P. 1992: Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression Cancer Research 52(20): 5775-5779
Lange, P.H.; Fraley, E.E. 1988: Controversies in the management of low volume stage Ii nonseminomatous germ cell testicular cancer Seminars in Oncology 15(4): 324-334
Archontovasilis, F.; Katsaragakis, S.; Lagoudiannakis, E.E.; Tsekouras, D.; Genetzakis, M.; Markogiannakis, H.; Albanopoulos, K.; Manouras, A. 2008: Postchemotherapy resection of a metastatic retroperitoneal nonseminomatous germ cell tumor of the testes Minerva Urologica e Nefrologica 60(1): 69-70
Krengli, M.; Pastore, G.; Invernizzi, A.; Maffei, S. 1987: Chemo-radiotherapeutic treatment of non-seminoma germ cell tumors of the testis in the advanced stage Minerva Medica 78(4): 209-213
Droz, J.P.; Kramar, A.; Caillaud, J.M.; Bellet, D.; Wibault, P.; Court, B.H. 1985: A multivariate analysis of prognostic factors in advanced stage of non seminomatous germ cell tumors of the testis (NSGCTT) Progress in Clinical and Biological Research 203: 269-270
Coffin, C.M.; Ewing, S.; Dehner, L.P. 1985: Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features Archives of Pathology and Laboratory Medicine 109(6): 555-559
Yatsuyanagi, E.; Kusajima, K.; Suzuki, M.; Hirano, T.; Sakurada, T.; Kikuchi, Y.; Sugawara, Y. 2004: Induction chemotherapy and radical resection for primary nonseminomatous mediastinal germ cell tumor (NSGCT); report of a case Kyobu Geka. Japanese Journal of Thoracic Surgery 57(2): 168-171
Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650
Vogl, S.E.; Camacho, F.J.; Kaplan, B.H.; O'Donnell, M.R. 1984: Phase Ii trial of vindesine in advanced squamous cell cancer of the head and neck Cancer Treatment Reports 68(3): 559-560